Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 30
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publicación Artículo científico (JournalArticle)

A novel intelligent approach for man‐in‐the‐middle attacks detection over internet of things environments based on message queuing telemetry transport

  • Michelena, Álvaro
  • Aveleira Mata, José Antonio
  • Jove, Esteban
  • Bayón Gutiérrez, Martín
  • Novais, Paulo
  • Romero, Oscar Fontenla
  • Calvo‐Rolle, José Luis
  • Alaiz Moretón, Héctor
[EN] One of the most common attacks is man-in-the-middle (MitM) which, due to its complex behaviour, is difficult to detect by traditional cyber-attack detection systems. MitM attacks on internet of things systems take advantage of special features of the protocols and cause system disruptions, making them invisible to legitimate elements. In this work, an intrusion detection system (IDS), where intelligent models can be deployed, is the approach to detect this type of attack considering network alterations. Therefore, this paper presents a novel method to develop the intelligent model used by the IDS, being this method based on a hybrid process. The first stage of the process implements a feature extraction method, while the second one applies different supervised classification techniques, both over a message queuing telemetry transport (MQTT) dataset compiled by authors in previous works. The contribution shows excellent performance for any compared classification methods. Likewise, the best results are obtained using the method with the highest computational cost. Thanks to this, a functional IDS will be able to prevent MQTT attacks., SI, Publicación en abierto financiada por el Consorcio de Bibliotecas Universitarias de Castilla y León (BUCLE), con cargo al Programa Operativo 2014ES16RFOP009 FEDER 2014-2020 DE CASTILLA Y LEÓN, Actuación:20007-CL - Apoyo Consorcio BUCLE
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction

  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Sapena, Victor|||0000-0003-4379-6486
  • García Criado, Ángeles|||0000-0003-3536-4288
  • Darnell, Anna
  • Forner, Alejandro|||0000-0002-9014-4950
  • Belmonte, Ernest|||0000-0003-3572-9769
  • Sanduzzi Zamparelli, Marco|||0000-0003-3795-3705
  • Rimola, Jordi|||0000-0002-1814-4198
  • Soler-Perromat, Alexandre|||0000-0003-2531-2484
  • Llarch, Neus|||0000-0003-3209-0453
  • Iserte, Gemma|||0000-0003-3908-8743
  • Mauro, Ezequiel|||0000-0002-0757-7676
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Ríos, José|||0000-0002-0716-8784
  • Bruix, Jordi|||0000-0002-9826-0753
  • Vilana, Ramon|||0000-0002-2249-1926
  • Reig, María|||0000-0002-5711-9534
Background: Ablation is a first-line treatment for Barcelona Clinic Liver Cancer (BCLC)-0/A hepatocellular carcinoma (HCC). However, there are scarce data about patients' outcomes after recurrence. The present study evaluates the impact of patient and tumor characteristics at baseline and at recurrence on the Clinical Decision-Making process. Methods: We evaluated BCLC-0/A patients treated with percutaneous ablation from January 2010 to November 2018. Clinical and radiological data such as age, tumor location at ablation, pattern of recurrence/progression, and comorbidities during follow-up were registered. Tumor location was divided into 'suboptimal' vs. 'optimal' locations for ablation. The Clinical Decision-Making was based on tumor burden, liver dysfunction, or comorbidities. The statistical analysis included the time-to-recurrence/progression, censoring at time of death, date of last follow-up or liver transplantation, and time-to-event was estimated by the Kaplan-Meier method and Cox regression models to evaluate the risk of an event of death and change of treatment strategy. Results: A total of 225 patients [39.1% BCLC-0 and 60.9% BCLC-A] were included, 190 had unifocal HCC and 82.6% were ≤3 cm. The complete response rate and median overall survival were 96% and 60.7 months. The HCC nodules number (Hazard Ratio-HR 3.1), Child-Pugh (HR 2.4), and Albumin-Bilirubin score (HR 3.2) were associated with increased risk of death during follow-up. HCC in 'suboptimal location' presented a shorter time to recurrence. When comorbidities prevented further loco-regional or systemic treatment, the risk of death was significantly increased (HR 2.0, p = 0.0369) in comparison to those who received treatment. Conclusions: These results expose the impact of non-liver comorbidities when considering treatment for recurrence after ablation in the real-world setting and in research trials. Ultimately, we identified an orphan population for which effective interventions are needed.
Repisalud
Publicación Artículo científico (JournalArticle)

Embryological-origin-dependent differences in homeobox expression in adult aorta: role in regional phenotypic variability and regulation of NF-κB activity

  • Trigueros-Motos, Laia
  • Gonzalez-Granado, Jose Maria
  • Cheung, Christine
  • Fernández, Patricia
  • Sanchez-Cabo, Fatima
  • Dopazo, Ana
  • Sinha, Sanjay
  • Andres, Vicente
OBJECTIVE: Different vascular beds show differing susceptibility to the development of atherosclerosis, but the molecular mechanisms underlying these differences are incompletely understood. This study aims to identify factors that contribute to the phenotypic heterogeneity of distinct regions of the adult vasculature. APPROACH AND RESULTS: High-throughput mRNA profiling in adult mice reveals higher expression of the homeobox paralogous genes 6 to 10 (Hox6-10) in the athero-resistant thoracic aorta (TA) than in the athero-susceptible aortic arch (AA). Higher homeobox gene expression also occurs in rat and porcine TA, and is maintained in primary smooth muscle cells isolated from TA (TA-SMCs) compared with cells from AA (AA-SMCs). This region-specific homeobox gene expression pattern is also observed in human embryonic stem cells differentiated into neuroectoderm-SMCs and paraxial mesoderm-SMCs, which give rise to AA-SMCs and TA-SMCs, respectively. We also find that, compared with AA and AA-SMCs, TA and TA-SMCs have lower activity of the proinflammatory and proatherogenic nuclear factor-κB (NF-κB) and lower expression of NF-κB target genes, at least in part attributable to HOXA9-dependent inhibition. Conversely, NF-κB inhibits HOXA9 promoter activity and mRNA expression in SMCs. CONCLUSION: Our findings support a model of Hox6-10-specified positional identity in the adult vasculature that is established by embryonic cues independently of environmental factors and is conserved in different mammalian species. Differential homeobox gene expression contributes to maintaining phenotypic differences between SMCs from athero-resistant and athero-susceptible regions, at least in part through feedback regulatory mechanisms involving inflammatory mediators, for example, reciprocal inhibition between HOXA9 and NF-κB.
Repisalud
Publicación Artículo científico (JournalArticle)

Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses

  • Cruz-Adalia, Aránzazu
  • Ramirez-Santiago, Guillermo
  • Osuna-Pérez, Jesús
  • Torres-Torresano, Mónica
  • Zorita, Virginia
  • Martínez-Riaño, Ana
  • Boccasavia, Viola
  • Borroto, Aldo
  • Martinez del Hoyo, Gloria
  • Gonzalez-Granado, Jose Maria
  • Alarcón, Balbino
  • Sanchez-Madrid, Francisco
  • Veiga, Esteban
Bacterial phagocytosis and antigen cross-presentation to activate CD8+ T cells are principal functions of professional antigen presenting cells. However, conventional CD4+ T cells also capture and kill bacteria from infected dendritic cells in a process termed transphagocytosis (also known as transinfection). Here, we show that transphagocytic T cells present bacterial antigens to naive CD8+ T cells, which proliferate and become cytotoxic in response. CD4+ T-cell-mediated antigen presentation also occurs in vivo in the course of infection, and induces the generation of central memory CD8+ T cells with low PD-1 expression. Moreover, transphagocytic CD4+ T cells induce protective anti-tumour immune responses by priming CD8+ T cells, highlighting the potential of CD4+ T cells as a tool for cancer immunotherapy.
Repisalud
Publicación Artículo científico (JournalArticle)

Nuclear envelope lamin-A couples actin dynamics with immunological synapse architecture and T cell activation

  • Gonzalez-Granado, Jose Maria
  • Silvestre-Roig, Carlos
  • Rocha-Perugini, Vera
  • Trigueros-Motos, Laia
  • Cibrian, Danay
  • Morlino, Giulia
  • Blanco-Berrocal, Marta
  • Osorio, Fernando Garcia
  • Freije, José María Pérez
  • López-Otín, Carlos
  • Sanchez-Madrid, Francisco
  • Andres, Vicente
In many cell types, nuclear A-type lamins regulate multiple cellular functions, including higher-order genome organization, DNA replication and repair, gene transcription, and signal transduction; however, their role in specialized immune cells remains largely unexplored. We showed that the abundance of A-type lamins was almost negligible in resting naïve T lymphocytes, but was increased upon activation of the T cell receptor (TCR). The increase in lamin-A was an early event that accelerated formation of the immunological synapse between T cells and antigen-presenting cells. Polymerization of F-actin in T cells is a critical step for immunological synapse formation, and lamin-A interacted with the linker of nucleoskeleton and cytoskeleton (LINC) complex to promote F-actin polymerization. We also showed that lamin-A expression accelerated TCR clustering and led to enhanced downstream signaling, including extracellular signal-regulated kinase 1/2 (ERK1/2) signaling, as well as increased target gene expression. Pharmacological inhibition of the ERK pathway reduced lamin-A-dependent T cell activation. Moreover, mice lacking lamin-A in immune cells exhibited impaired T cell responses in vivo. These findings underscore the importance of A-type lamins for TCR activation and identify lamin-A as a previously unappreciated regulator of the immune response.
Repisalud
Publicación Artículo científico (JournalArticle)

High-resolution imaging of intravascular atherogenic inflammation in live mice

  • Chevre, Raphael
  • Gonzalez-Granado, Jose Maria
  • Megens, Remco T A
  • Sreeramkumar, Vinatha
  • Silvestre-Roig, Carlos
  • Molina-Sanchez, Pedro
  • Weber, Christian
  • Soehnlein, Oliver
  • Hidalgo, Andres
  • Andres, Vicente
RATIONALE: The inflammatory processes that initiate and propagate atherosclerosis remain poorly understood, largely because defining the intravascular behavior of immune cells has been technically challenging. Respiratory and pulsatile movements have hampered in vivo visualization of leukocyte accumulation in athero-prone arteries at resolutions achieved in other tissues. OBJECTIVE: To establish and to validate a method that allows high-resolution imaging of inflammatory leukocytes and platelets within the carotid artery of atherosusceptible mice in vivo. METHODS AND RESULTS: We have devised a procedure to stabilize the mouse carotid artery mechanically without altering blood dynamics, which dramatically enhances temporal and spatial resolutions using high-speed intravital microscopy in multiple channels of fluorescence. By applying this methodology at different stages of disease progression in atherosusceptible mice, we first validated our approach by assessing the recruitment kinetics of various leukocyte subsets and platelets in athero-prone segments of the carotid artery. The high temporal and spatial resolution allowed the dissection of both the dynamic polarization of and the formation of subcellular domains within adhered leukocytes. We further demonstrate that the secondary capture of activated platelets on the plaque is predominantly mediated by neutrophils. Finally, we couple this procedure with triggered 2-photon microscopy to visualize the 3-dimensional movement of leukocytes in intimate contact with the arterial lumen. CONCLUSIONS: The improved imaging of diseased arteries at subcellular resolution presented here should help resolve many outstanding questions in atherosclerosis and other arterial disorders.
Repisalud
Publicación Artículo científico (JournalArticle)

Disruption of the CCL1-CCR8 axis inhibits vascular Treg recruitment and function and promotes atherosclerosis in mice

  • Vila-Caballer, Marian
  • Gonzalez-Granado, Jose Maria
  • Zorita, Virginia
  • Abu Nabah, Yafa N
  • Silvestre-Roig, Carlos
  • del Monte, Alberto
  • Molina-Sanchez, Pedro
  • Ait-Oufella, Hafid
  • Andres-Manzano, Maria J.
  • Sanz, María J
  • Weber, Christian
  • Kremer, Leonor
  • Gutiérrez, Julio
  • Mallat, Ziad
  • Andres, Vicente
The CC chemokine 1 (CCL1, also called I-309 or TCA3) is a potent chemoattractant for leukocytes that plays an important role in inflammatory processes and diseases through binding to its receptor CCR8. Here, we investigated the role of the CCL1-CCR8 axis in atherosclerosis. We found increased expression of CCL1 in the aortas of atherosclerosis-prone fat-fed apolipoprotein E (Apoe)-null mice; moreover, in vitro flow chamber assays and in vivo intravital microscopy demonstrated an essential role for CCL1 in leukocyte recruitment. Mice doubly deficient for CCL1 and Apoe exhibited enhanced atherosclerosis in aorta, which was associated with reduced plasma levels of the anti-inflammatory interleukin 10, an increased splenocyte Th1/Th2 ratio, and a reduced regulatory T cell (Treg) content in aorta and spleen. Reduced Treg recruitment and aggravated atherosclerosis were also detected in the aortas of fat-fed low-density lipoprotein receptor-null mice treated with CCR8 blocking antibodies. These findings demonstrate that disruption of the CCL1-CCR8 axis promotes atherosclerosis by inhibiting interleukin 10 production and Treg recruitment and function.
Repisalud
Publicación Artículo científico (JournalArticle)

Lamin A/C augments Th1 differentiation and response against vaccinia virus and Leishmania major

  • Toribio-Fernandez, Raquel
  • Zorita, Virginia
  • Rocha-Perugini, Vera
  • Iborra, Salvador
  • Martinez del Hoyo, Gloria
  • Chevre, Raphael
  • Dorado, Beatriz
  • Sancho, David
  • Sanchez-Madrid, Francisco
  • Andres, Vicente
  • Gonzalez-Granado, Jose Maria
Differentiation of naive CD4(+) T-cells into functionally distinct T helper (Th) subsets is critical to immunity against pathogen infection. Little is known about the role of signals emanating from the nuclear envelope for T-cell differentiation. The nuclear envelope protein lamin A/C is induced in naive CD4(+) T-cells upon antigen recognition and acts as a link between the nucleus and the plasma membrane during T-cell activation. Here we demonstrate that the absence of lamin A/C in naive T-cell reduces Th1 differentiation without affecting Th2 differentiation in vitro and in vivo. Moreover, Rag1(-/-) mice reconstituted with Lmna(-/-)CD4(+)CD25(-) T-cells and infected with vaccinia virus show weaker Th1 responses and viral removal than mice reconstituted with wild-type T-cells. Th1 responses and pathogen clearance upon Leishmania major infection were similarly diminished in mice lacking lamin A/C in the complete immune system or selectively in T-cells. Lamin A/C mediates Th1 polarization by a mechanism involving T-bet and IFN gamma production. Our results reveal a novel role for lamin A/C as key regulator of Th1 differentiation in response to viral and intracellular parasite infections.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Plasma fibroblast activation protein is decreased in acute heart failure despite cardiac tissue upregulation

  • Delgado-Arija, Marta
  • Genovés, Patricia
  • Pérez-Carrillo, Lorena
  • González-Torrent, Irene
  • Giménez-Escamilla, Isaac
  • Martínez-Dolz, Luis
  • Portolés, Manuel
  • Tarazón, Estefanía
  • Roselló-Lletí, Esther
[EN] Background Cardiac fibroblast activation protein (FAP) has an emerging role in heart failure (HF). A paradoxical reduction in its levels in pathological conditions associated with acute processes has been observed. We aimed to identify FAP cardiac tissue expression and its relationship with the main cardiac fibrosis-related signaling pathways, and to compare plasma FAP levels in acute and chronic HF patients. Methods Transcriptomic changes were assessed via mRNA/ncRNA-seq in left ventricle tissue from HF patients (n¿=¿57) and controls (n¿=¿10). Western blotting and immunohistochemistry were used to explore FAP protein levels and localization in cardiac tissue. ELISA was performed to examine plasma FAP levels in acute HF (n¿=¿48), chronic HF (n¿=¿15) and control samples (n¿=¿7). Results FAP overexpression in cardiac tissue is related to the expression of molecules directly involved in cardiac fibrosis, such as POSTN, THBS4, MFAP5, COL1A2 and COL3A1 (P¿<¿0.001), and is directly and inversely related to pro- and antifibrotic microRNAs, respectively. The observed FAP overexpression is not reflected in plasma. Circulating FAP levels were lower in acute HF patients than in controls (P¿<¿0.05), while chronic HF patients did not show significant changes. The clinical variables analyzed, such as functional class or etiology, do not affect plasma FAP concentrations. Conclusions We determined that in HF cardiac tissue, FAP is related to the main cardiac fibrosis signaling pathways as well as to pro- and antifibrotic microRNAs. Additionally, an acute phase of HF decreases plasma FAP levels despite the upregulation observed in cardiac tissue and regardless of other clinical conditions., This work was supported by the National Institute of Health Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III [Projects: PI20/01469 and PI20/00071 co-funded by European Union; Miguel Servet contracts: CP18/00145 co-funded by European Union, European Social Fund (ESF) The ESF invests in your future and CP21/00041 co-funded by European Union; contract FI21/00186 and FI21/00034]; Consorcio Centro de Investi&#8209; gación Biomédica en Red [CIBERCV, under Grant CB16/11/00261]; Ministry of Universities and the European Recovery, Transformation and Resilience Plan (PRTR, Next Generation EU) [ Ayuda Margarita Salas para la formación de jóvenes doctores : contract: MS21-162]; Ministry of Science and Innovation (MCIN, 10.13039/501100011033) and State Investigation Agency (AEI) [Project CNS2022-135769] co-funded by European Union Next Generation EU and PRTR; Conselleria de educación, universidades y empleo [Project CIA&#8209; ICO/2022/246, contract CIACIF/2022/429].
Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publicación Artículo científico (JournalArticle)

Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions

  • Díez Villares, Sandra
  • García Varela, Lara
  • Groba de Antas, Soraya
  • Caeiro Rey, José Ramón
  • Carpintero-Fernandez, Paula
  • Mayán, María D.
  • Aguiar Fernández, Pablo
  • Fuente, María de la
Intra-articular (IA) administration of drugs for the treatment of diseases such as rheumatoid arthritis, osteoarthritis and psoriatic arthritis is a common strategy; however, the rapid clearance from the synovial fluid restricts their effectivity due to the limited retention time. Drug Delivery Systems (DDS) are currently being developed to increase their joint retention time. This study compares the biodistribution and retention time of a senolytic peptide (PEP), with potential application in osteoarthritis disease, and this senolytic peptide encapsulated in a DDS based on a lipid nanoemulsion (PEPsingle bondNE) by using positron emission tomography (PET) imaging. To this aim, the PEP was conjugated with a chelating agent (DFO) and radiolabeled with zirconium-89 (89Zr). Then, [89Zr]-PEP was encapsulated in a novel nanoemulsion formulation, composed by vitamin E, sphingomyelin, and a lipid-PEG. Afterward, healthy rats were administered with either the [89Zr]-PEP or the [89Zr]-PEP-NE via IA injection and underwent PET scans at 0.5-, 24-, 48-, 72-, 168-, 240- and 336 h post-injection. To assess the biodistribution of both radiotracers, several volume-of-interest were manually drawn in different organs of the rat body and the %ID/organ was calculated. The [89Zr]-PEP was successfully encapsulated in the NE and their physicochemical properties were minimally affected by the radiolabeling buffer. Adequate stability of both [89Zr]-PEP and [89Zr]-PEP-NE was found in synovial fluid over 72 h. Quantitative data from PET images revealed a significantly higher [89Zr]-PEP-NE retention in the injected knee than with [89Zr]-PEP in all follow-up PET scans. The [89Zr]-PEP %ID/organ values in the liver and kidney were significantly higher than those from [89Zr]-PEP-NE, which might indicate a faster elimination of the [89Zr]-PEP. Therefore, the study highlights the higher retention time on the target site of the [89Zr]-PEP-NE which may improve the therapeutic effects of the peptide. Thereby, the novel nanoemulsion formulation seems to be a successful DDS for IA injection. In addition, these results represent the first study that evaluates the distribution of a PET-guided DDS after its IA administration.
idUS. Depósito de Investigación de la Universidad de Sevilla
Publicación Artículo científico (JournalArticle)

Remarks on the determination of the Landau gauge OPE for the asymmetric three gluon vertex

  • Soto, F. de
  • Rodríguez Quintero, J.
We compute a compact operator product expansion (OPE) formula describing power corrections to the perturbative expression for the asymmetric momentum subtraction–(MOM̃−) renormalized running coupling constant up to the leading logarithm. By the use of a phenomenological hypothesis leading to the factorization of the condensates through a perturbative vacuum insertion, the only relevant condensate in the game is ⟨A2⟩. The validity of the OPE formula is tested by searching for a good-quality coherent description of previous lattice evaluations of the MOM̃-renormalized gluon propagator and running coupling., European Community’s Human Potential Program HPRN-CT-2000-00145, DGICyT PB98- 1111 FP A2000-1592-C03-02
idUS. Depósito de Investigación de la Universidad de Sevilla
Publicación Artículo científico (JournalArticle)

Instantons and the ⟨A2⟩ condensate

  • Boucaud, Ph.
  • Leroy, J. P.
  • Le Yaouanc, A.
  • Micheli, A.
  • Pène, Olivier
  • Soto, F. de
  • Donini, A.
  • Moutarde, H.
  • Rodríguez Quintero, J.
We argue that the ⟨A2OPE⟩ condensate found in the Landau gauge on lattices, when an operator product expansion of Green’s functions is performed, might be explained by instantons. We use cooling to estimate the instanton contribution and extrapolate back the result to the thermalized configuration. The resulting ⟨A2inst⟩ is similar to ⟨A2OPE⟩., M.U.R.S.T. 1833/2001, European Union Human Potential Program HPRN-CT-2000-00145
idUS. Depósito de Investigación de la Universidad de Sevilla
Publicación Artículo científico (JournalArticle)

Transparent expression of the A2 condensate’s renormalization

  • Boucaud, Ph.
  • Soto, F. de
  • Le Yaouanc, A.
  • Leroy, J. P.
  • Micheli, J.
  • Moutarde, H.
  • Pène, Olivier
  • Rodríguez Quintero, J.
We give a more transparent understanding of the vacuum expectation value of the renormalized local operator A2 by relating it to the gluon propagator integrated over the momentum. The quadratically divergent perturbative contribution is subtracted and the remainder, dominantly due to the O(1/p2) correction to the perturbative propagator at large p2 is logarithmically divergent. This provides a transparent derivation of the fact that this O(1/p2) term is related to the vacuum expectation value of the local A2 operator and confirms a previous claim based on the operator product expansion (OPE) of the gluon propagator. At leading logarithms the agreement is quantitative, with a standard running factor, between the local A2 condensate renormalized as described above and the one renormalized in the OPE context. This result supports the claim that the BRST invariant Landau-gauge A2 condensate might play an important role in describing the QCD vacuum., European Union Human Potential Program HPRN-CT- 2000-00145
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Extracellular Vesicles Enriched in Connexin 43 Promote a Senescent Phenotype in Bone and Synovial Cells Contributing to Osteoarthritis Progression

  • Varela-Eirín, Marta
  • Carpintero-Fernández, Paula
  • Guitián-Caamaño, Amanda
  • Varela Vázquez, Adrián
  • García-Yuste, Alejandro
  • Sánchez-Temprano, Agustín
  • Bravo López, Susana Belén
  • Yáñez-Cabanas, José
  • Fonseca, Eduardo
  • Largo, R
  • Mobasheri, Ali
  • Caeiro, José Ramón
  • Mayán, María D.
[Abstract] The accumulation of senescent cells is a key characteristic of aging, leading to the progression of age-related diseases such as osteoarthritis (OA). Previous data from our laboratory has demonstrated that high levels of the transmembrane protein connexin 43 (Cx43) are associated with a senescent phenotype in chondrocytes from osteoarthritic cartilage. OA has been reclassified as a musculoskeletal disease characterized by the breakdown of the articular cartilage affecting the whole joint, subchondral bone, synovium, ligaments, tendons and muscles. However, the mechanisms that contribute to the spread of pathogenic factors throughout the joint tissues are still unknown. Here, we show for the first time that small extracellular vesicles (sEVs) released by human OA-derived chondrocytes contain high levels of Cx43 and induce a senescent phenotype in targeted chondrocytes, synovial and bone cells contributing to the formation of an inflammatory and degenerative joint environment by the secretion of senescence-associated secretory associated phenotype (SASP) molecules, including IL-1ß and IL-6 and MMPs. The enrichment of Cx43 changes the protein profile and activity of the secreted sEVs. Our results indicate a dual role for sEVs containing Cx43 inducing senescence and activating cellular plasticity in target cells mediated by NF-kß and the extracellular signal-regulated kinase 1/2 (ERK1/2), inducing epithelial-to-mesenchymal transition (EMT) signalling programme and contributing to the loss of the fully differentiated phenotype. Our results demonstrated that Cx43-sEVs released by OA-derived chondrocytes spread senescence, inflammation and reprogramming factors involved in wound healing failure to neighbouring tissues, contributing to the progression of the disease among cartilage, synovium, and bone and probably from one joint to another. These results highlight the importance for future studies to consider sEVs positive for Cx43 as a new biomarker of disease progression and new target to treat OA., This work was supported in part through funding from Health Institute ‘Carlos III’ (ISCIII, Spain), the European Regional Development Fund, ‘A way of making Europe’ from the European Union (to MDM): grant PI19/00145; a grant from the Joint Transnational Call for Proposals for “European Innovative Research & Technological Development Projects in Nanomedicine” EURONANOMED III (AC21_2/00026) (to MDM); a grant from Xunta de Galicia (IN607B2020/12) (to MDM) and from H2020, Future and Emerging Technologies (grant 858014 “PANACHE”) to MDM. MV-E was funded with a predoctoral (ED481A-2015/188) and post-doctoral fellowship (IN606B-2019/004) from Xunta de Galicia. AG-C was funded with a predoctoral fellowship (FIS20/00310) from ISCIII. PC-F was funded with a post-doctoral fellowship and a grant from Xunta de Galicia (INB606B 2017/014 and IN606C 2021/006). We thank members of the CellCOM group for helpful technical suggestion, María Dolores Álvarez Alvariño (CHUS) for generously collecting tissue samples in the operating room after surgery and Arantxa Tabernero (INCYL, University of Salamanca) for kindly providing the human Cx43 plasmid used in this study, Xunta de Galicia; IN607B2020/12, Xunta de Galicia; ED481A-2015/188, Xunta de Galicia; IN606B-2019/004, Xunta de Galicia; INB606B 2017/014, Xunta de Galicia; IN606C 2021/006
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

New Therapeutic Strategies for Osteoarthritis by Targeting Sialic Acid Receptors

  • Carpintero-Fernández, Paula
  • Varela-Eirín, Marta
  • Lacetera, Alessandra
  • Gago-Fuentes, Raquel
  • Fonseca, Eduardo
  • Martín-Santamaría, Sonsoles
  • Mayán, María D.
[Abstract] Osteoarthritis (OA) is the most common degenerative joint disease characterized by articular cartilage degradation and joint degeneration. The articular cartilage is mainly formed by chondrocytes and a collagen-proteoglycan extracellular matrix that contains high levels of glycosylated proteins. It was reported that the shift from glycoproteins containing α-2,6-linked sialic acids to those that contain α-2,3 was associated with the onset of common types of arthritis. However, the pathophysiology of α-2,3-sialylation in cartilage has not been yet elucidated. We show that cartilage from osteoarthritic patients expresses high levels of the α-2,3-sialylated transmembrane mucin receptor, known as podoplanin (PDPN). Additionally, the Maackia amurensis seed lectin (MASL), that can be utilized to target PDPN, attenuates the inflammatory response mediated by NF-kB activation in primary chondrocytes and protects human cartilage breakdown ex vivo and in an animal model of arthritis. These findings reveal that specific lectins targeting α-2,3-sialylated receptors on chondrocytes might effectively inhibit cartilage breakdown. We also present a computational 3D molecular model for this interaction. These findings provide mechanistic information on how a specific lectin could be used as a novel therapy to treat degenerative joint diseases such as osteoarthritis., This work was funded by the Spanish Society for Rheumatology (SER-2013) and the Spanish Society for Research on Bone and Mineral Metabolism (FEIOMM-2016) (to M.D.M.) and by the grant PI13/00591, PI16/00035, and PI19/00145 from the Health Institute “Carlos III” (ISCIII, Spain) and was cofinanced by the European Regional Development Funds, “A way of making Europe” from the European Union (to M.D.M.). Paula Carpintero-Fernández has a postdoctoral fellowship from Xunta de Galicia (IN606B 2017/014) Two predoctoral fellowships from Xunta de Galicia to Marta Varela-Eirin (ED481A 2015/188) and Raquel Gago-Fuentes (PRE/2012/165) and from University of A Coruña—INDITEX and CICA-INIBIC (AGRUP2015/05). The Spanish Ministry for Economy and Competitiveness (MINECO) grants CTQ2014-57141-R and CTQ2017-88353-R (to S.M.-S.) is gratefully acknowledged., Xunta de Galicia; IN606B 2017/014, Xunta de Galicia; ED481A 2015/188, Xunta de Galicia; PRE/2012/165
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Senolytic Activity of Small Molecular Polyphenols from Olive Restores Chondrocyte Redifferentiation and Promotes a Pro-Regenerative Environment in Osteoarthritis

  • Varela-Eirín, Marta
  • Carpintero-Fernández, Paula
  • Sánchez-Temprano, Agustín
  • Varela Vázquez, Adrián
  • Luis Paíno, Carlos
  • Casado-Díaz, Antonio
  • Calañas-Continente, Alfonso
  • Mato-Abad, Virginia
  • Fonseca, Eduardo
  • Kandouz, Mustapha
  • Blanco, Alfonso
  • Caeiro, José Ramón
  • Mayán, María D.
[Abstract] Articular cartilage and synovial tissue from patients with osteoarthritis (OA) show an overactivity of connexin43 (Cx43) and accumulation of senescent cells associated with disrupted tissue regeneration and disease progression. The aim of this study was to determine the effect of oleuropein on Cx43 and cellular senescence for tissue engineering and regenerative medicine strategies for OA treatment. Oleuropein regulates Cx43 promoter activity and enhances the propensity of hMSCs to differentiate into chondrocytes and bone cells, reducing adipogenesis. This small molecule reduce Cx43 levels and decrease Twist-1 activity in osteoarthritic chondrocytes (OACs), leading to redifferentiation, restoring the synthesis of cartilage ECM components (Col2A1 and proteoglycans), and reducing the inflammatory and catabolic factors mediated by NF-kB (IL-1ß, IL-6, COX-2 and MMP-3), in addition to lowering cellular senescence in OACs, synovial and bone cells. Our in vitro results demonstrate the use of olive-derived polyphenols, such as oleuropein, as potentially effective therapeutic agents to improve chondrogenesis of hMSCs, to induce chondrocyte re-differentiation in OACs and clearing out senescent cells in joint tissues in order to prevent or stop the progression of the disease., Xunta de Galicia; IN607B 2017/21, Xunta de Galicia; ED481A-2015/188, Xunta de Galicia; IN606B-2019/004, Xunta de Galicia; IN606B-2017/014, This work was supported in part through funding from the Spanish Foundation for Research on Bone and Mineral Metabolism (FEIOMM), grant PRECIPITA-2015-000139 from the FECYT-Ministry of Economy and Competitiveness (to M.D.M.), grant PI16/00035 and PI19/00145 from the Health Institute ‘Carlos III’ (ISCIII, Spain), the European Regional Development Fund, ‘A way of making Europe’ from the European Union (to M.D.M.) and a grant from Xunta de Galicia IN607B 2017/21 (to M.D.M.). M.V.-E. was funded with a predoctoral (ED481A-2015/188) and a postdoctoral fellowship (IN606B-2019/004) from Xunta de Galicia. P.C.-F. was funded with a postdoctoral fellowship (IN606B-2017/014) from Xunta de Galicia.
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Genome Wide CRISPR/Cas9 Screen Identifies the Coagulation Factor IX (F9) as a Regulator of Senescence

  • Carpintero-Fernández, Paula
  • Borghesan, Michela
  • Eleftheriadou, Olga
  • Pan-Castillo, Belén
  • Fafián-Labora, J.A.
  • Mitchell, Tom P.
  • Yuste, Alejandro
  • Ogrunc, Muge
  • Nightingale, Thomas D.
  • Mayán, María D.
  • O'Loghlen, Ana
[Abstract] During this last decade, the development of prosenescence therapies has become an attractive strategy as cellular senescence acts as a barrier against tumour progression. In this context, CDK4/6 inhibitors induce senescence and reduce tumour growth in breast cancer patients. However, even though cancer cells are arrested after CDK4/6 inhibitor treatment, genes regulating senescence in this context are still unknown limiting their antitumour activity. Here, using a functional genome-wide CRISPR/Cas9 genetic screen we found several genes that participate in the proliferation arrest induced by CDK4/6 inhibitors. We find that downregulation of the coagulation factor IX (F9) using sgRNA and shRNA prevents the cell cycle arrest and senescent-like phenotype induced in MCF7 breast tumour cells upon Palbociclib treatment. These results were confirmed using another breast cancer cell line, T47D, and with an alternative CDK4/6 inhibitor, Abemaciclib, and further tested in a panel of 22 cancer cells. While F9 knockout prevents the induction of senescence, treatment with a recombinant F9 protein was sufficient to induce a cell cycle arrest and senescence-like state in MCF7 tumour cells. Besides, endogenous F9 is upregulated in different human primary cells cultures undergoing senescence. Importantly, bioinformatics analysis of cancer datasets suggest a role for F9 in human tumours. Altogether, these data collectively propose key genes involved in CDK4/6 inhibitor response that will be useful to design new therapeutic strategies in personalised medicine in order to increase their efficiency, stratify patients and avoid drug resistance., This paper was funded by the BBSRC (BB/P000223/1), the MRC (MR/K501372/1), The Royal Society (RG170399) and Barts Charity (MGU0497 and G-002158) grants to A.O. M.M. was funded by PI19/00145, IN607B2020/12 and 858014. J.F.L. is funded by Xunta de Galicia (ED481B 2017/117). M.B. was funded by MRC (MR/K501372/1). T.P.M. was funded by a QMUL PhD programme and T.D.N.’s lab is currently funded by a Barts Charity project grant (MGU0534). P.C.F. is currently funded by GAIN (IN606C 2021/006) Xunta de Galicia, Reino Unido. Biotechnology and Biological Sciences Research Council; BB/P000223/1, Reino Unido. Medical Research Council; MR/K501372/1, Reino Unido. Royal Society; RG170399, Barts Charity (Londres); MGU0497, Barts Charity (Londres); G-002158, Xunta de Galicia; IN607B2020/12, Xunta de Galicia; ED481B 2017/117, Barts Charity (Londres); MGU0534, Xunta de Galicia; IN606C 2021/006
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

Long-term association between water intake and kidney function in a population at high cardiovascular risk

  • Paz Graniel, Indira
  • Valle Hita, Cristina
  • Babio, Nancy
  • Serra Majem, Lluís
  • Vioque, Jesús
  • Zomeño, M. Dolores
  • Corella Piquer, Dolores
  • Pintó Sala, Xavier
  • Cano-Ibáñez, Naomi
  • Tur, Josep A.
  • Cuadrado-Soto, Esther
  • Martínez, José Alfredo
  • Díaz López, Andrés
  • Torres-Collado, Laura
  • Goday, Alberto
  • Fernández-Carrión, Rebeca
  • Nissenshon, Mariela
  • Riera-Mestre, Antoni
  • Garrido-Garrido, Eva
  • Bouzas, Cristina
  • Abete, Itziar
  • Daimiel, Lidia
  • Cornejo-Pareja, Isabel María
  • Vázquez Ruiz, Zenaida
  • Khoury, Nadine
  • Pérez-Vega, Karla Alejandra
  • Salas Salvadó, Jordi
Objectives The evidence on water intake in the prevention of kidney function decline is scarce at population level in well-being individuals at high cardiovascular risk. Therefore, we aimed to longitudinally evaluate the associations between total water intake and subtypes and kidney function, through estimated-Glomerular Filtration Rate (eGFR). Methods Three-year prospective analysis conducted in 1986 older adults (aged 55–75 year) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus study. Water intake was assessed using validated beverage and food frequency questionnaires. Serum creatinine-based eGFR (SCr-based eGFR; ml/min/1.73 m2) was estimated using the CKD-EPI equation at baseline, one-year and 3-years of follow-up. Mixed-effects linear regression models were fitted to evaluate the associations between baseline total water intake and subtypes, and SCr-based eGFR over 3-years of follow-up. Results Participants in the highest baseline tertile of total water intake, plain water and water from all fluids showed a lower decrease in SCr-based eGFR after 3-years of follow-up, compared to those in the lowest tertile. Participants with the highest tap water consumption showed a lower SCr-based eGFR decline after 1-year and 3-years of follow-up, in comparerd to participants in the lowest intake category (T3 vs. T1: β: 1.4 ml/min/1.73 m2; 95%CI: 0.5–2.3, β: 1.0; 95%CI: 0.1–2.0, respectively). Conclusions Plain water rather than other water sources, and especially tap water, was associated with lower kidney function decline assessed through eGFR over 3-years of follow-up, in older individuals at high cardiovascular risk., info:eu-repo/semantics/publishedVersion
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Dietary fat patterns and outcomes in acute pancreatitis in Spain

  • García-Rayado, G.
  • Varela-Moreiras, G.
  • Lanas, Á.
  • Ferrández, Á.
  • Balza-Lareu, N.
  • Cervera, J.I.
  • Bodenlle-Bello, M.P.
  • Argüelles-Arias, A.M.
  • Latorre, P.
  • Udaondo-Cascante, M.A.
  • Soria-de-la-Cruz, M.J.
  • Lariño-Noia, J.
  • García-Figueiras, R.
  • Gil-García-Ollauri, C.
  • Ituarte-Uriarte, R.
  • Rosales-Alexander, C.L.
  • Soriano, J.
  • Rodríguez-Peláez, M.
  • Mesa-Álvarez, A.
  • Oblitas, E.
  • Menso, M.M.
  • Bertoletti, F.
  • Rodríguez-Prada, J.I.
  • Guzmán-Suárez, S.
  • Closa, D.
  • de-Madaria, E.
Background/Objective: Evidence from basic and clinical studies suggests that unsaturated fatty acids (UFAs) might be relevant mediators of the development of complications in acute pancreatitis (AP). Objective: The aim of this study was to analyze outcomes in patients with AP from regions in Spain with different patterns of dietary fat intake. Materials and Methods: A retrospective analysis was performed with data from 1, 655 patients with AP from a Spanish prospective cohort study and regional nutritional data from a Spanish cross-sectional study. Nutritional data considered in the study concern the total lipid consumption, detailing total saturated fatty acids, UFAs and monounsaturated fatty acids (MUFAs) consumption derived from regional data and not from the patient prospective cohort. Two multivariable analysis models were used: (1) a model with the Charlson comorbidity index, sex, alcoholic etiology, and recurrent AP; (2) a model that included these variables plus obesity. Results: In multivariable analysis, patients from regions with high UFA intake had a significantly increased frequency of local complications, persistent organ failure (POF), mortality, and moderate-to-severe disease in the model without obesity and a higher frequency of POF in the model with obesity. Patients from regions with high MUFA intake had significantly more local complications and moderate-to-severe disease; this significance remained for moderate-to-severe disease when obesity was added to the model. Conclusions: Differences in dietary fat patterns could be associated with different outcomes in AP, and dietary fat patterns may be a pre-morbid factor that determines the severity of AP. UFAs, and particulary MUFAs, may influence the pathogenesis of the severity of AP.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Long-term association between water intake and kidney function in a population at high cardiovascular risk

  • Paz Graniel, Indira
  • Valle Hita, Cristina
  • Babio, Nancy
  • Serra Majem, Lluís
  • Vioque, Jesús
  • Zomeño, M. Dolores
  • Corella Piquer, Dolores
  • Pintó Sala, Xavier
  • Cano-Ibáñez, Naomi
  • Tur, Josep A.
  • Cuadrado-Soto, Esther
  • Martínez, José Alfredo
  • Díaz López, Andrés
  • Torres-Collado, Laura
  • Goday, Alberto
  • Fernández-Carrión, Rebeca
  • Nissenshon, Mariela
  • Riera-Mestre, Antoni
  • Garrido-Garrido, Eva
  • Bouzas, Cristina
  • Abete, Itziar
  • Daimiel, Lidia
  • Cornejo-Pareja, Isabel María
  • Vázquez Ruiz, Zenaida
  • Khoury, Nadine
  • Pérez-Vega, Karla Alejandra
  • Salas Salvadó, Jordi
Objectives The evidence on water intake in the prevention of kidney function decline is scarce at population level in well-being individuals at high cardiovascular risk. Therefore, we aimed to longitudinally evaluate the associations between total water intake and subtypes and kidney function, through estimated-Glomerular Filtration Rate (eGFR). Methods Three-year prospective analysis conducted in 1986 older adults (aged 55–75 year) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus study. Water intake was assessed using validated beverage and food frequency questionnaires. Serum creatinine-based eGFR (SCr-based eGFR; ml/min/1.73 m2) was estimated using the CKD-EPI equation at baseline, one-year and 3-years of follow-up. Mixed-effects linear regression models were fitted to evaluate the associations between baseline total water intake and subtypes, and SCr-based eGFR over 3-years of follow-up. Results Participants in the highest baseline tertile of total water intake, plain water and water from all fluids showed a lower decrease in SCr-based eGFR after 3-years of follow-up, compared to those in the lowest tertile. Participants with the highest tap water consumption showed a lower SCr-based eGFR decline after 1-year and 3-years of follow-up, in comparerd to participants in the lowest intake category (T3 vs. T1: β: 1.4 ml/min/1.73 m2; 95%CI: 0.5–2.3, β: 1.0; 95%CI: 0.1–2.0, respectively). Conclusions Plain water rather than other water sources, and especially tap water, was associated with lower kidney function decline assessed through eGFR over 3-years of follow-up, in older individuals at high cardiovascular risk., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Iron-loaded transferrin (Tf) is detrimental whereas iron-free Tf confers protection against brain ischemia by modifying blood Tf saturation and subsequent neuronal damage

  • Gregorio-Rocasolano Barbany, Núria de|||0000-0001-5248-7525
  • Martí Sistac, Octavi
  • Ponce, Jovita
  • Castello-Ruiz, María|||0000-0001-7814-4045
  • Millán Torné, Mònica|||0000-0002-4692-5936
  • Guirao, Verónica
  • García Yébenes, Isaac
  • Salom, Juan B.|||0000-0002-4162-6101
  • Ramos Cabrer, Pedro
  • Alborch, Enrique
  • Lizasoain, Ignacio
  • Castillo, José
  • Dávalos, Antoni|||0000-0003-2949-5679
  • Gasull Dalmau, Teresa|||0000-0002-9321-1741
Despite transferrin being the main circulating carrier of iron in body fluids, and iron overload conditions being known to worsen stroke outcome through reactive oxygen species (ROS)-induced damage, the contribution of blood transferrin saturation (TSAT) to stroke brain damage is unknown. The objective of this study was to obtain evidence on whether TSAT determines the impact of experimental ischemic stroke on brain damage and whether iron-free transferrin (apotransferrin, ATf)-induced reduction of TSAT is neuroprotective. We found that experimental ischemic stroke promoted an early extravasation of circulating iron-loaded transferrin (holotransferrin, HTf) to the ischemic brain parenchyma. In vitro, HTf was found to boost ROS production and to be harmful to primary neuronal cultures exposed to oxygen and glucose deprivation. In stroked rats, whereas increasing TSAT with exogenous HTf was detrimental, administration of exogenous ATf and the subsequent reduction of TSAT was neuroprotective. Mechanistically, ATf did not prevent extravasation of HTf to the brain parenchyma in rats exposed to ischemic stroke. However, ATf in vitro reduced NMDA-induced neuronal uptake of HTf and also both the NMDA-mediated lipid peroxidation derived 4-HNE and the resulting neuronal death without altering Ca²⁺ -calcineurin signaling downstream the NMDA receptor. Removal of transferrin from the culture media or blockade of transferrin receptors reduced neuronal death. Together, our data establish that blood TSAT exerts a critical role in experimental stroke-induced brain damage. In addition, our findings suggest that the protective effect of ATf at the neuronal level resides in preventing NMDA-induced HTf uptake and ROS production, which in turn reduces neuronal damage.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Broad Phenotypes of Disorders/Differences of Sex Development in MAMLD1 Patients Through Oligogenic Disease

  • Flück, Christa E.
  • Audí, Laura
  • Fernández Cancio, Mónica|||0000-0003-1872-3488
  • Sauter, Kay-Sara
  • Martinez de LaPiscina, Idoia
  • Castaño, Luis|||0000-0003-0437-9401
  • Esteva, Isabel
  • Camats Tarruella, Núria|||0000-0002-4863-8201
Disorders/differences of sex development (DSD) are the result of a discordance between chromosomal, gonadal, and genital sex. DSD may be due to mutations in any of the genes involved in sex determination and development in general, as well as gonadal and/or genital development specifically. MAMLD1 is one of the recognized DSD genes. However, its role is controversial as some MAMLD1 variants are present in normal individuals, several MAMLD1 mutations have wild-type activity in functional studies, and the Mamld1-knockout male mouse presents with normal genitalia and reproduction. We previously tested nine MAMLD1 variants detected in nine 46,XY DSD patients with broad phenotypes for their functional activity, but none of the mutants, except truncated L210X, had diminished transcriptional activity on known target promoters CYP17A1 and HES3. In addition, protein expression of MAMLD1 variants was similar to wild-type, except for the truncated L210X. We hypothesized that MAMLD1 variants may not be sufficient to explain the phenotype in 46,XY DSD individuals, and that further genetic studies should be performed to search for additional hits explaining the broad phenotypes. We therefore performed whole exome sequencing (WES) in seven of these 46,XY patients with DSD and in one 46,XX patient with ovarian insufficiency, who all carried MAMLD1 variants. WES data were filtered by an algorithm including disease-tailored lists of MAMLD1-related and DSD-related genes. Fifty-five potentially deleterious variants in 41 genes were identified; 16/55 variants were reported in genes in association with hypospadias, 8/55 with cryptorchidism, 5/55 with micropenis, and 13/55 were described in relation with female sex development. Patients carried 1-16 variants in 1-16 genes together with their MAMLD1 variation. Network analysis of the identified genes revealed that 23 genes presented gene/protein interactions with MAMLD1. Thus, our study shows that the broad phenotypes of individual DSD might involve multiple genetic variations contributing towards the complex network of sexual de.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

  • Corominas Argente del Castillo, Josep|||0000-0002-5351-9469
  • Sapena, Victor|||0000-0003-4379-6486
  • Sanduzzi Zamparelli, Marco|||0000-0003-3795-3705
  • Millán, Cristina
  • Samper, Esther
  • Llarch, Neus|||0000-0003-3209-0453
  • Iserte, Gemma|||0000-0003-3908-8743
  • Torres, Ferran|||0000-0002-7355-7913
  • Da Fonseca, Leonardo G.|||0000-0002-0216-3618
  • Muñoz-Martínez, S|||0000-0003-0663-0575
  • Forner, Alejandro|||0000-0002-9014-4950
  • Bruix, Jordi|||0000-0002-9826-0753
  • Boix, Loreto|||0000-0002-6015-3901
  • Reig, María|||0000-0002-5711-9534
Hepatocellular carcinoma is the second cause of cancer-related death worldwide. Of those advanced-stage patients who are treated with sorafenib, those who develop early dermatologic adverse events have a better prognosis. These events are possibly immune-related. Therefore, we analyzed the phenotype of 52 sorafenib-treated patients' circulating lymphocytes throughout treatment. We found that different co-stimulatory and immune exhaustion markers, such as Programmed cell death protein 1 (PD-1) and DNAX accessory molecule 1 (DNAM-1) amongst others, correlate with the probability of developing these adverse events, both before and during the treatment. We also compared the phenotype of those lymphocytes expressing DNAM-1 with those that do not, and while NK DNAM-1-expressing cells have a co-stimulatory phenotype, T DNAM-1-expressing cells are immune-suppressors. Overall, we set a rationale for the combination of sorafenib and immune-targeted therapies; and for the use of immune markers (such as DNAM-1) for patients' prognosis evaluation. Advanced hepatocellular carcinoma patients treated with sorafenib who develop early dermatologic adverse events (eDAEs) have a better prognosis. This may be linked to immune mechanisms, and thus, it is relevant to assess the association between peripheral immunity and the probability of developing eDAEs. Peripheral blood mononuclear cells of 52 HCC patients treated with sorafenib were analyzed at baseline and throughout the first eight weeks of therapy. T, B, Natural Killer cells, and their immune checkpoints expression data were characterized by flow cytometry. Cytokine release and immune-suppression assays were carried out ex vivo. Cox baseline and time-dependent regression models were applied to evaluate the probability of increased risk of eDAEs. DNAM-1, PD-1, CD69, and LAG-3 in T cells, plus CD16 and LAG-3 in NK cells, are significantly associated with the probability of developing eDAEs. While NK DNAM-1 + cells express activation markers, T DNAM-1 + cells induce immune suppression and show immune exhaustion. This is the first study to report an association between immune checkpoints expression in circulating immune cells and the increased incidence of eDAEs. Our results support the hypothesis for an off-target role of sorafenib in immune modulation. We also describe a novel association between DNAM-1 and immune exhaustion in T cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs

  • Díaz-González, Álvaro|||0000-0003-3610-2263
  • Sapena, Victor|||0000-0003-4379-6486
  • Boix, Loreto|||0000-0002-6015-3901
  • Torres, Ferran|||0000-0002-7355-7913
  • Sanduzzi Zamparelli, Marco|||0000-0003-3795-3705
  • Da Fonseca, Leonardo G.|||0000-0002-0216-3618
  • Llarch, Neus|||0000-0003-3209-0453
  • Iserte, Gemma|||0000-0003-3908-8743
  • Guedes, Cassia
  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Darnell, Anna
  • Belmonte, Ernest|||0000-0003-3572-9769
  • Rimola, Jordi|||0000-0002-1814-4198
  • Forner, Alejandro|||0000-0002-9014-4950
  • Ayuso, Carmen|||0000-0002-9606-6957
  • Bruix, Jordi|||0000-0002-9826-0753
  • Reig, María|||0000-0002-5711-9534
Despite atezolizumab and bevacizumab (A + B) is currently the first-line treatment for hepatocellular carcinoma (HCC) patients, some patients will not be adequate for this combination. In the setting of sorafenib some adverse events have been proposed as prognostic factors. To characterize the early diarrhoea development as prognostic factor in 344 HCC patients. The development of early diarrhoea in sorafenib treatment defined as patients who developed diarrhoea and needed dose modification within the first 60 days of treatment (e-diarrhoea) and 3-grouping variables were analysed: Patients with e-diarrhoea, patients who developed diarrhoea after the first 60 days of treatment (L-diarrhoea) and patients that never developed diarrhoea (never diarrhoea). The median overall survival in sorafenib treated patients was significantly different across groups (6.8 months for e-diarrhoea, 26.7 months for L-diarrhoea and 13.3 months for never-diarrhoea). The emergence of e-diarrhoea was associated with poor outcomes (hazard ratio [HR] 1.84 [95%CI 1.15-2.95]), while there was no increased/decreased risk of dismal evolution in patients with L-diarrhoea (HR 0.66 [95%CI 0.42-1.03]). The emergence of e-diarrhoea in HCC patients treated with sorafenib is an early predictor of dismal evolution under this therapy. Thus, prompt identification of these non-responders may be useful for an early switch to second-line therapies. Established knowledge on this subject What are the significant and/or new findings of this study?.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

"She's Surrounded by Loved Ones, but Feeling Alone", A Relational Approach to Loneliness

  • Valenzuela García, Hugo|||0000-0002-6195-9149
  • Lubbers, Miranda J.|||0000-0001-8398-6044
  • Molina, José Luis|||0000-0002-2932-2690
Loneliness poses one of the significant problems of our modern post-industrial societies. Current research on loneliness has been developed primarily by psychology, biomedicine, nursing, and other health-related disciplines, showing a sur-prising number of variables and risk factors involved in the experience of loneliness, along with positive correlations with premature mortality and morbidity. However, most of these analyses overlook the social interactions and context in which loneliness is experienced. Drawing on a subsample (N = 24) of Spanish "mothers" from impoverished families, the article proposes a mixed-method approach (both relational and interpretative) that may potentially complement quantitative approaches, showing relational and contextual factors that may contribute to a better understanding of the subjective dimension of loneliness.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnosis of Genetic White Matter Disorders by Singleton Whole-Exome and Genome Sequencing Using Interactome-Driven Prioritization

  • Schlüter, Agatha|||0000-0001-6732-1528
  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Verdura, Edgard|||0000-0003-3856-2060
  • Vélez-Santamaría, Valentina
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Fourcade, Stéphane|||0000-0002-8031-5007
  • Planas-Serra, Laura|||0000-0002-2586-0897
  • Martínez, Juan José
  • Guilera, Cristina|||0000-0003-0715-9332
  • Girós, Marisa
  • Artuch, R.|||0000-0002-3422-9685
  • Yoldi-Petri, María Eugenia
  • O'Callaghan, Maria del Mar|||0000-0002-1896-1622
  • García-Cazorla, Angels|||0000-0001-9853-688X
  • Armstrong, Judith|||0000-0003-0588-9307
  • Marti, Itxaso
  • Mondragon Rezola, Elisabet
  • Redin, Claire
  • Mandel, Jean Louis
  • Conejo, David
  • Sierra-Córcoles, Concepción
  • Beltran i Agulló, Sergi|||0000-0002-2810-3445
  • Gut, Marta|||0000-0002-4063-7159
  • Vázquez, Elida
  • Del Toro, Mireia|||0000-0002-8163-1853
  • Troncoso, Mónica
  • Pérez-Jurado, Luis Alberto|||0000-0002-1988-3005
  • González Gutiérrez-Solana, Luis|||0000-0003-2890-4565
  • Lopez de Munain, Adolfo|||0000-0002-9509-4032
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • Aguilera-Albesa, Sergio|||0000-0003-3540-1448
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Pujol, Aurora|||0000-0002-9606-0600
Genetic white matter disorders (GWMD) are of heterogeneous origin, with.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Outcome of liver cancer patients with SARS-CoV-2 infection, An International, Multicentre, Cohort Study

  • Muñoz-Martínez, S.|||0000-0003-0663-0575
  • Sapena, Victor|||0000-0003-4379-6486
  • Forner, Alejandro|||0000-0002-9014-4950
  • Bruix, Jordi|||0000-0002-9826-0753
  • Sanduzzi Zamparelli, Marco|||0000-0003-3795-3705
  • Ríos, José|||0000-0002-0716-8784
  • Bouattour, Mohamed|||0000-0002-3919-4135
  • El-Kassas, Mohamed|||0000-0002-3396-6894
  • Leal, Cassia R. G.
  • Mocan, Tudor|||0000-0001-7785-6403
  • Nault, Jean-Charles|||0000-0002-4875-9353
  • Alves, Rogerio C. P.
  • Reeves, Helen L.|||0000-0003-0359-9795
  • Da Fonseca, Leonardo G.|||0000-0002-0216-3618
  • García-Juárez, Ignacio|||0000-0003-2400-1887
  • Pinato, David James|||0000-0002-3529-0103
  • Varela Calvo, Maria|||0000-0003-4288-2593
  • Alqahtani, Saleh|||0000-0003-2017-3526
  • Alvares-da-Silva, Mario R.|||0000-0002-5001-246X
  • Bandi, Juan C.|||0000-0001-9733-1938
  • Rimassa, Lorenza|||0000-0001-9957-3615
  • Lozano, Mar|||0000-0001-7099-0810
  • González Santiago, Jesús M.|||0000-0003-4667-4492
  • Tacke, Frank|||0000-0001-6206-0226
  • Sala, Margarita
  • Anders, María|||0000-0002-2238-5322
  • Lachenmayer, Anja|||0000-0002-5879-5737
  • Piñero, Federico
  • França, Alex
  • Guarino, Maria|||0000-0002-0460-4122
  • Elvevi, Alessandra
  • Cabibbo, Giuseppe|||0000-0002-0946-3859
  • Peck-Radosavljevic, Markus|||0000-0002-0597-2728
  • Rojas, Ángela|||0000-0003-0853-4800
  • Vergara, Mercedes|||0000-0002-6971-8657
  • Braconi, Chiara|||0000-0003-4835-1259
  • Pascual, Sonia|||0000-0002-4265-5019
  • Perelló, Christie|||0000-0003-0234-2330
  • Mello, Vivianne
  • Rodríguez Lope, Carlos|||0000-0002-6713-8800
  • Acevedo, Juan|||0000-0003-4507-2422
  • Villani, Rosanna|||0000-0001-9875-019X
  • Hollande, Clemence|||0000-0002-2287-0635
  • Vilgrain, Valérie
  • Tawheed, Ahmed|||0000-0002-9382-8733
  • Ferguson Theodoro, Carmem|||0000-0001-6605-1060
  • Sparchez, Zeno
  • Blaise, Lorraine
  • Viera-Alves, Daniele E.
  • Watson, Robyn
  • Carrilho, Flair J.
  • Moctezuma-Velázquez, Carlos|||0000-0003-2367-2742
  • D'Alessio, Antonio
  • Iavarone, Massimo|||0000-0003-3493-6504
  • Reig, María|||0000-0002-5711-9534
Information about the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with liver cancer is lacking. This study characterizes the outcomes and mortality risk in this population. Multicentre retrospective, cross-sectional, international study of liver cancer patients with SARS-CoV-2 infection registered between February and December 2020. Clinical data at SARS-CoV-2 diagnosis and outcomes were registered. Two hundred fifty patients from 38 centres were included, 218 with hepatocellular carcinoma (HCC) and 32 with intrahepatic cholangiocarcinoma (iCCA). The median age was 66.5 and 64.5 years, and 84.9% and 21.9% had cirrhosis in the HCC and iCCA cohorts respectively. Patients had advanced cancer stage at SARS-CoV-2 diagnosis in 39.0% of the HCC and 71.9% of the iCCA patients. After a median follow-up of 7.20 (IQR: 1.84-11.24) months, 100 (40%) patients have died, 48% of the deaths were SARS-CoV-2-related. Forty (18.4%) HCC patients died within 30-days. The death rate increase was significantly different according to the BCLC stage (6.10% [95% CI 2.24-12.74], 11.76% [95% CI 4.73-22.30], 20.69% [95% CI 11.35-31.96] and 34.52% [95% CI 17.03-52.78] for BCLC 0/A, B, C and D, respectively; p =.0017). The hazard ratio was 1.45 (95% CI 0.49-4.31; p =.5032) in BCLC-B versus 0/A, and 3.13 (95% CI 1.29-7.62; p =.0118) in BCLC-C versus 0/A in the competing risk Cox regression model. Nineteen out of 32 iCCA (59.4%) died, and 12 deaths were related to SARS-CoV-2 infection. This is the largest cohort of liver cancer patients infected with SARS-CoV-2. It characterizes the 30-day mortality risk of SARS-CoV-2 infected patients with HCC during this period.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A high-throughput microtiter plate screening assay to quantify and differentiate species in dual-species biofilms

  • Campo Pérez, Víctor|||0000-0003-3161-9984
  • Alcàcer-Almansa, Júlia|||0000-0002-8688-3128
  • Julián, Esther|||0000-0002-6558-3978
  • Torrents, Eduard|||0000-0002-3010-1609
Pathogenic bacteria form biofilms during infection, and polymicrobial biofilms are the most frequent manifestation. Biofilm attachment, maturation, and/or antibiotic sensitivity are mainly evaluated with microtiter plate assays, in which bacteria are stained to enable the quantification of the biomass by optical absorbance or fluorescence emission. However, using these methods to distinguish different species in dual-species or polymicrobial biofilms is currently impossible. Colony-forming unit counts from homogenized dual-species biofilms on selective agar medium allow species differentiation but are time-consuming for a high-throughput screening. Thus, reliable, feasible, and fast methods are urgently needed to study the behavior of polymicrobial and dual-species communities. This study shows that Pseudomonas aeruginosa and Burkholderia cenocepacia strains expressing specific fluorescent or bioluminescent proteins permit the more efficient study of dual-species biofilms compared to other methods that rely on measuring the total biomass. Combining fluorescence and bioluminescence measurements allows an independent analysis of the different microbial species within the biofilm, indicating the degree of presence of each one over time during a dual-species biofilm growth. The quantitative strategies developed in this work are reproducible and recommended for dual-species biofilm studies with high-throughput microtiter plate approaches using strains that can constitutively express fluorescent or bioluminescent proteins.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy

  • Verdura, Edgard|||0000-0003-3856-2060
  • Rodríguez-Palmero, Agustí|||0000-0002-4141-5515
  • Vélez-Santamaria, Valentina
  • Planas-Serra, Laura|||0000-0002-2586-0897
  • de la Calle, Irene|||0000-0002-2227-1640
  • Raspall-Chaure, Miquel|||0000-0002-3132-3342
  • Roubertie, Agathe
  • Benkirane, Mehdi
  • Saettini, Francesco|||0000-0003-0767-3905
  • Pavinato, Lisa|||0000-0002-7630-8365
  • Mandrile, Giorgia
  • O'Leary, Melanie
  • O'Heir, Emily
  • Barredo, Estibaliz
  • Chacón, Almudena
  • Michaud, Vincent|||0000-0002-5788-392X
  • Goizet, Cyril
  • Ruiz, Montserrat|||0000-0003-0466-2653
  • Schlüter, Agatha|||0000-0001-6732-1528
  • Rouvet, Isabelle
  • Sala-Coromina, Júlia|||0000-0001-5116-6316
  • Fossati, Chiara
  • Iascone, Maria
  • Canonico, Francesco
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • de Souza, Precilla
  • Adams, David R.
  • Casasnovas, Carlos|||0000-0002-7933-4681
  • Rehm, Heidi L.
  • Mefford, Heather C.|||0000-0001-7188-522X
  • González Gutiérrez-Solana, Luis|||0000-0003-2890-4565
  • Brusco, Alfredo|||0000-0002-8318-7231
  • Koenig, Michel
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Pujol, Aurora|||0000-0002-9606-0600
Phosphoinositides are lipids that play a critical role in processes such as cellular signalling, ion channel activity and membrane trafficking. When mutated, several genes that encode proteins that participate in the metabolism of these lipids give rise to neurological or developmental phenotypes. PI4KA is a phosphoinositide kinase that is highly expressed in the brain and is essential for life. Here we used whole exome or genome sequencing to identify 10 unrelated patients harbouring biallelic variants in PI4KA that caused a spectrum of conditions ranging from severe global neurodevelopmental delay with hypomyelination and developmental brain abnormalities to pure spastic paraplegia. Some patients presented immunological deficits or genito-urinary abnormalities. Functional analyses by western blotting and immunofluorescence showed decreased PI4KA levels in the patients' fibroblasts. Immunofluorescence and targeted lipidomics indicated that PI4KA activity was diminished in fibroblasts and peripheral blood mononuclear cells. In conclusion, we report a novel severe metabolic disorder caused by PI4KA malfunction, highlighting the importance of phosphoinositide signalling in human brain development and the myelin sheath. Verdura et al. report a novel rare brain metabolic disorder caused by recessive mutations in PI4KA, which encodes an enzyme with a pivotal role in phosphoinositide metabolism at the cell membrane. The description of this syndrome will simplify the identification of undiagnosed cases with similar clinical features.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication, A Population-Based Cohort Study

  • Ríos, José|||0000-0002-0716-8784
  • Sapena, Victor|||0000-0003-4379-6486
  • Mariño, Zoe|||0000-0001-6321-9534
  • Bruix, Jordi|||0000-0002-9826-0753
  • Forns, Xavier|||0000-0002-8188-1764
  • Morros, Rosa|||0000-0001-6752-8748
  • Reig, María|||0000-0002-5711-9534
  • Torres, Ferran|||0000-0002-7355-7913
  • Pontes García, Caridad|||0000-0002-3274-6048
Background and Objectives: Direct-acting antivirals (DAAs) offer a high rate of hepatitis C virus (HCV) eradication. However, concerns on the risk of cancer after HCV eradication remain. Our study aimed at quantifying the incidence of cancer in patients treated with anti-HCV therapies in Catalonia (Spain) and their matched controls. Methods: This was a population-based study using real-world data from the public healthcare system of Catalonia between 2012 and 2016. Propensity score matching was performed in patients with HCV infection treated with interferon-based therapy (IFN), sequential IFN and DAA (IFN+DAA), and DAA only (DAA) with concurrent controls. We estimated the annual incidence of overall cancer, hepatocellular carcinoma, and non-liver cancer of HCV-treated patients and their corresponding rate ratios. Results: The study included 11,656 HCV-treated patients and 49,545 controls. We found statistically significant increases in the rate of overall cancer for IFN+DAA-treated (rate ratio [RR] 1.77, 95% confidence interval [CI] 1.27-2.46) and DAA-treated patients (RR 1.90, 95% CI 1.66-2.19) and in the rate of HCC for IFN-treated (RR 1.50, 95% CI 1.02-2.22), IFN+DAA-treated (RR 3.89, 95% CI 2.26-6.69), and DAA-treated patients (RR 6.45, 95% CI 4.90-8.49) compared with their corresponding controls. Moreover, DAA-treated patients with cirrhosis showed an increased rate of overall cancer versus those without cirrhosis (RR 1.92, 95% CI 1.51-2.44). Conclusions: Results showed that overall cancer and hepatocellular carcinoma incidence in Catalonia was significantly higher among HCV-treated patients compared with matched non-HCV-infected controls, and risks were higher in patients with cirrhosis. An increased awareness of the potential occurrence of uncommon malignant events and monitoring after HCV eradication therapy may benefit patients.